This week, we are joined again by 340B Health President and CEO Maureen Testoni. Maureen discusses and analyzes major developments for the 340B program that occurred this fall. These include updates on the community pharmacy dispute, legislation on drug pricing, and the U.S. Supreme Court hearing arguments on Medicare pay cuts to 340B hospitals. 

Court Decisions in the 340B Community Pharmacy Dispute  

More drug companies in recent months have announced plans to restrict 340B pricing on drugs dispensed at community pharmacies. Maureen discusses that development, recaps multiple court decisions affecting the dispute, and describes how 340B Health and the administration are responding to the new developments. 

How Hospitals Can Be Heard

Maureen discusses immediate advocacy actions 340B hospitals should take to ensure their voices are heard and to help the government escalate its enforcement. 

The Latest on Capitol Hill  

Congress is considering drug pricing legislation that could impact 340B savings. Maureen also gives updates on legislation to protect 340B eligibility during the COVID-19 public health emergency.  

340B on the U.S. Supreme Court Docket  

Maureen provides her analysis of oral arguments before the U.S. Supreme Court in a case to determine whether Medicare officials have the authority to impose Medicare cuts on 340B hospitals. 

This is our final episode of 2021. Check out all our episodes on the 340B Insight podcast website. You also can stay updated on all 340B Health news and information by visiting our homepage. If you have any questions you’d like us to cover in this podcast, email us at [email protected].

Resources 

1. 340B Hospital Sign-On Letter to the Department of Health & Human Services
2. Statement on Amgen Restricting 340B Discounts Through Community-Based Pharmacies 
3. Under Pressure, Clovis Oncology Backs Off 340B Rebate Model
4. Supreme Court Case Oral Argument on Medicare Cuts to 340B Hospitals
5. 340B Coalition Winter Conference 2022